Zelluna Immunotherapy
Biotechnology ResearchView the employees at
Zelluna Immunotherapy-
Geir Christian Melen Finance Director at Zelluna Immunotherapy
-
Oslo, Oslo, Norway
-
Top 5%
Artur Cieslar-Pobuda Scientist at Zelluna Immunotherapy-
Oslo, Oslo, Norway
-
Rising Star
Inês Cardoso Senior Scientist at Zelluna Immunotherapy-
Oslo, Oslo, Norway
-
Top 5%
Sylvie Pollmann Group Leader Preclinical Research at Zelluna Immunotherapy-
Greater Oslo Region
-
Rising Star
Overview
Zelluna Immunotherapy is a company pioneering the development of allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company is developing a portfolio of tumor specific TCRs to guide NK cells with the aim to induce cancer responses that are safe, efficient and durable. For more info please visit www.zelluna.com
-